Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
36,212,313
-
Share change
-
+11,922,155
-
Total reported value
-
$61,554,460
-
Put/Call ratio
-
97%
-
Price per share
-
$1.70
-
Number of holders
-
80
-
Value change
-
+$20,355,780
-
Number of buys
-
46
-
Number of sells
-
31
Institutional Holders of ACELRX PHARMACEUTICALS INC - COM (ACRX) as of Q1 2021
As of 31 Mar 2021 ACELRX PHARMACEUTICALS INC - COM (ACRX) had 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 36,212,313 shares of stock of the company.
Largest 10 holders included BlackRock Inc., D. E. Shaw & Co., Inc., VANGUARD GROUP INC, Rock Springs Capital Management LP, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, NORTHERN TRUST CORP, and BANK OF AMERICA CORP /DE/.
This table shows 80 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.